Literature DB >> 10506274

Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?

P D Griffiths1, S Blaser, W Mukonoweshuro, D Armstrong, G Milo-Mason, S Cheung.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the natural history of the high signal intensities shown on long TR sequences-neurofibromatosis type 1 bright objects (NBO)-in children with neurofibromatosis type 1 (NF1). We have paid particular attention to the development of tumors in these areas of abnormality.
METHODS: During a 12-month period in 1992 to 1993, 46 children with clinically proven NF1 had a magnetic resonance (MR) examination at our institution. These were reviewed along with any previous or subsequent MR examinations that had been performed. We recorded the number, volume, and distribution of the abnormal high signal intensities and their change with time when serial examinations were performed.
RESULTS: NBO were found in 93% of 46 children with NF1 on the original cross-sectional study. The most common anatomic sites were the globus pallidus (30.4%), cerebellum (23.5%), and midbrain (16.2%). The number and volume of NBO varied significantly with age. NBO were uncommon in children younger than 4 years but were very common and extensive between 4 to 10 years. A significant reduction in the number and volume of NBO was demonstrated in children older than 10 years as shown on both the cross-sectional and longitudinal portions of the study. Eight brain tumors (nonoptic pathway) were demonstrated in the 46 children (17%) with 1 child having two tumors. Only 1 child had symptoms referable to the tumor at the time of diagnosis. Five tumors developed in NBO that were documented on serial MR examinations. All those cases developed in children aged 7 to 12 years, and all these children had higher than average numbers and volumes of NBO.
CONCLUSIONS: NBO occur commonly in children with NF1 and are most prevalent between the ages of 4 and 10. We have shown a high frequency of brain tumors in our children with NF1, but the majority of these were asymptomatic. We have demonstrated proliferative change NBO in 11% of 46 children. Most NBO regress with age and seem to be benign, however, young children with a large number and volume of NBO should be followed closely with regular MR examinations because of an increased risk of proliferative change. neurofibromatosis type 1, magnetic resonance, tumor, astrocytoma, childhood.

Entities:  

Mesh:

Year:  1999        PMID: 10506274     DOI: 10.1542/peds.104.4.e49

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

2.  The dentate nucleus in children: normal development and patterns of disease.

Authors:  Aoife McErlean; Khaled Abdalla; Veronica Donoghue; Stephanie Ryan
Journal:  Pediatr Radiol       Date:  2010-01-28

3.  Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Authors:  E L Wignall; P D Griffiths; N G Papadakis; I D Wilkinson; L I Wallis; O Bandmann; P E E Cowell; N Hoggard
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 4.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

5.  Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up.

Authors:  Felix Distelmaier; Raimund Fahsold; Guido Reifenberger; Martina Messing-Juenger; Jörg Schaper; Dominik T Schneider; Ulrich Göbel; Ertan Mayatepek; Thorsten Rosenbaum
Journal:  Childs Nerv Syst       Date:  2006-08-29       Impact factor: 1.475

6.  Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis.

Authors:  Shunsuke Nakakura; Kunihiko Shiraki; Takaharu Yasunari; Yoko Hayashi; Shinsuke Ataka; Takeya Kohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 7.  Pediatric brain MRI in neurofibromatosis type I.

Authors:  Hans-J Mentzel; Jörg Seidel; Clemens Fitzek; Annegret Eichhorn; Susanna Vogt; Jürgen R Reichenbach; Felix Zintl; Werner A Kaiser
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

8.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16

9.  Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.

Authors:  Ignacio Pascual-Castroviejo; Samuel-Ignacio Pascual-Pascual
Journal:  Childs Nerv Syst       Date:  2012-09-22       Impact factor: 1.475

10.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.

Authors:  José Roberto Lopes Ferraz Filho; Marcos Pontes Munis; Antonio Soares Souza; Rafael Angelo Sanches; Eni Maria Goloni-Bertollo; Erika Cristina Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2008-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.